Scientists from the Royal Botanic Gardens, Kew, and their international partners, reveal today their pick of the top 10 ...

MAVIRET is the first and only oral eight-week pan-genotypic treatment option approved for people with acute or chronic ...

EG110A is a non-replicating HSV-1 vector designed to selectively silence the signals of type C sensory neurons responsible ...

During the Third Mind AI Summit prep, our “AI staff” formed an org chart, assigned ranks, and held grudges... raising a real ...

LOR is the first drug candidate with disease-modifying potential for osteoarthritis submitted for approval, demonstrating ...

A late operating system, a stopgap deal, and the accident that made DOS dominant A blog post by programmer Nemanja Trifunovic ...

The Arlington Police Department is celebrating the retirement of Corporal Dick Hill, who has dedicated 51 years of service to ...

To kick off the new year, reMarkable is doing even one better: for a limited time, you can take an additional $70 off the ...

Tokyo University of Science researchers developed a groundbreaking thin-film electrolyte, improving oxide-ion conductivity ...

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...

Tom Frary previews the action at Cagnes-sur-Mer on Monday, with a whole host of well-bred newcomers appearing on the card.

Distance is possible, and often desirable, but nothing is ever exactly the same in a prepared course. The real thing comes ...